
Marsha M. Tsay
Examiner (ID: 332, Phone: (571)272-2938 , Office: P/1656 )
| Most Active Art Unit | 1656 |
| Art Unit(s) | 1656, 1653 |
| Total Applications | 1124 |
| Issued Applications | 471 |
| Pending Applications | 130 |
| Abandoned Applications | 543 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5929818
[patent_doc_number] => 20110039777
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-17
[patent_title] => 'CANCER TREATMENT USING NATRIURETIC PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/908806
[patent_app_country] => US
[patent_app_date] => 2010-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12008
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20110039777.pdf
[firstpage_image] =>[orig_patent_app_number] => 12908806
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/908806 | Cancer treatment using natriuretic peptides | Oct 19, 2010 | Issued |
Array
(
[id] => 8430170
[patent_doc_number] => 20120252045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'METHOD OF ASSESSING ISLET FUNCTION'
[patent_app_type] => utility
[patent_app_number] => 13/393587
[patent_app_country] => US
[patent_app_date] => 2010-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8395
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/393587 | METHOD OF ASSESSING ISLET FUNCTION | Sep 2, 2010 | Abandoned |
Array
(
[id] => 8252404
[patent_doc_number] => 20120156723
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-21
[patent_title] => 'PROTEIN GLYCOSYLATION'
[patent_app_type] => utility
[patent_app_number] => 13/394073
[patent_app_country] => US
[patent_app_date] => 2010-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 9398
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394073
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/394073 | PROTEIN GLYCOSYLATION | Sep 2, 2010 | Abandoned |
Array
(
[id] => 7509888
[patent_doc_number] => 20110256106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'Methods and Compositions for Treating Intervertebral Disc Degeneration'
[patent_app_type] => utility
[patent_app_number] => 12/850516
[patent_app_country] => US
[patent_app_date] => 2010-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 42
[patent_figures_cnt] => 42
[patent_no_of_words] => 11568
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256106.pdf
[firstpage_image] =>[orig_patent_app_number] => 12850516
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/850516 | Methods and Compositions for Treating Intervertebral Disc Degeneration | Aug 3, 2010 | Abandoned |
Array
(
[id] => 6071210
[patent_doc_number] => 20110046061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-24
[patent_title] => 'Coagulation factor VII compositions and methods of making and using same'
[patent_app_type] => utility
[patent_app_number] => 12/806005
[patent_app_country] => US
[patent_app_date] => 2010-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 98750
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20110046061.pdf
[firstpage_image] =>[orig_patent_app_number] => 12806005
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/806005 | Coagulation factor VII compositions and methods of making and using same | Aug 1, 2010 | Issued |
Array
(
[id] => 7754581
[patent_doc_number] => 20120027746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'METHOD FOR GENERATING THROMBIN'
[patent_app_type] => utility
[patent_app_number] => 12/846944
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6511
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0027/20120027746.pdf
[firstpage_image] =>[orig_patent_app_number] => 12846944
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/846944 | METHOD FOR GENERATING THROMBIN | Jul 29, 2010 | Abandoned |
Array
(
[id] => 10642752
[patent_doc_number] => 09359610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-07
[patent_title] => 'Method for purifying GLA-domain coagulation proteins'
[patent_app_type] => utility
[patent_app_number] => 13/392963
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27919
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13392963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/392963 | Method for purifying GLA-domain coagulation proteins | Jul 29, 2010 | Issued |
Array
(
[id] => 8675662
[patent_doc_number] => 08383776
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-26
[patent_title] => 'Purification of factor XIII polypeptides from biological materials'
[patent_app_type] => utility
[patent_app_number] => 12/838593
[patent_app_country] => US
[patent_app_date] => 2010-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16824
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12838593
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/838593 | Purification of factor XIII polypeptides from biological materials | Jul 18, 2010 | Issued |
Array
(
[id] => 8522699
[patent_doc_number] => 20120322107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'METHODS OF INCREASING THE EXPRESSION YIELD OF VITAMIN K-DEPENDENT PROTEINS'
[patent_app_type] => utility
[patent_app_number] => 13/382933
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13395
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382933
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382933 | Methods of increasing the expression yield of vitamin K-dependent proteins | Jul 8, 2010 | Issued |
Array
(
[id] => 6270592
[patent_doc_number] => 20100254970
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'NGAL FOR REDUCTION AND AMELIORATION OF ISCHEMIC AND NEPHROTOXIC INJURIES'
[patent_app_type] => utility
[patent_app_number] => 12/817566
[patent_app_country] => US
[patent_app_date] => 2010-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 18550
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254970.pdf
[firstpage_image] =>[orig_patent_app_number] => 12817566
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/817566 | NGAL for reduction and amelioration of ischemic and nephrotoxic injuries | Jun 16, 2010 | Issued |
Array
(
[id] => 13125735
[patent_doc_number] => 10080782
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-09-25
[patent_title] => Hemoglobin compositions
[patent_app_type] => utility
[patent_app_number] => 12/797582
[patent_app_country] => US
[patent_app_date] => 2010-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27083
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 211
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12797582
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/797582 | Hemoglobin compositions | Jun 8, 2010 | Issued |
Array
(
[id] => 7790580
[patent_doc_number] => 20120052136
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'NOVEL HEAMOGLOBIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/318860
[patent_app_country] => US
[patent_app_date] => 2010-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7939
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20120052136.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318860
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318860 | Heamoglobin and uses thereof | May 6, 2010 | Issued |
Array
(
[id] => 6629570
[patent_doc_number] => 20100311658
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'MODIFIED VITAMIN K-DEPENDENT POLYPEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 12/770255
[patent_app_country] => US
[patent_app_date] => 2010-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 24305
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20100311658.pdf
[firstpage_image] =>[orig_patent_app_number] => 12770255
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/770255 | Modified vitamin K-dependent polypeptides | Apr 28, 2010 | Issued |
Array
(
[id] => 6379991
[patent_doc_number] => 20100316623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-16
[patent_title] => 'PHENYLALANINE HYDROXYLASE FUSION PROTEIN AND METHODS FOR TREATING PHENYLKETONURIA'
[patent_app_type] => utility
[patent_app_number] => 12/766193
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 9626
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0316/20100316623.pdf
[firstpage_image] =>[orig_patent_app_number] => 12766193
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/766193 | PHENYLALANINE HYDROXYLASE FUSION PROTEIN AND METHODS FOR TREATING PHENYLKETONURIA | Apr 22, 2010 | Abandoned |
Array
(
[id] => 8160694
[patent_doc_number] => 20120101263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-26
[patent_title] => 'METHOD OF PREPARING LOW-IRON LACTOFERRIN'
[patent_app_type] => utility
[patent_app_number] => 13/266020
[patent_app_country] => US
[patent_app_date] => 2010-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7566
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0101/20120101263.pdf
[firstpage_image] =>[orig_patent_app_number] => 13266020
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/266020 | Method of preparing low-iron lactoferrin | Apr 22, 2010 | Issued |
Array
(
[id] => 8381418
[patent_doc_number] => 20120225051
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-06
[patent_title] => 'TISSUE KALLIKREIN FOR THE TREATMENT OF HUNTINGTON\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 13/265357
[patent_app_country] => US
[patent_app_date] => 2010-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10683
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13265357
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/265357 | TISSUE KALLIKREIN FOR THE TREATMENT OF HUNTINGTON'S DISEASE | Apr 21, 2010 | Abandoned |
Array
(
[id] => 6321025
[patent_doc_number] => 20100196490
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 12/758413
[patent_app_country] => US
[patent_app_date] => 2010-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19540
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196490.pdf
[firstpage_image] =>[orig_patent_app_number] => 12758413
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/758413 | Compositions and methods of delivery of pharmacological agents | Apr 11, 2010 | Issued |
Array
(
[id] => 7744840
[patent_doc_number] => 20120022233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'COLLAGEN IMPLANT'
[patent_app_type] => utility
[patent_app_number] => 13/258998
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9221
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20120022233.pdf
[firstpage_image] =>[orig_patent_app_number] => 13258998
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/258998 | COLLAGEN IMPLANT | Mar 23, 2010 | Abandoned |
Array
(
[id] => 6231506
[patent_doc_number] => 20100184687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Purification of Glucagon-Like Peptides'
[patent_app_type] => utility
[patent_app_number] => 12/725828
[patent_app_country] => US
[patent_app_date] => 2010-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 13757
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0184/20100184687.pdf
[firstpage_image] =>[orig_patent_app_number] => 12725828
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/725828 | Purification of Glucagon-Like Peptides | Mar 16, 2010 | Abandoned |
Array
(
[id] => 7720315
[patent_doc_number] => 20120009650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-12
[patent_title] => 'COMPOSITIONS, METHODS AND KITS FOR PREPARING PLASMINOGEN AND PLASMIN PREPARED THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 13/147491
[patent_app_country] => US
[patent_app_date] => 2010-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 21374
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20120009650.pdf
[firstpage_image] =>[orig_patent_app_number] => 13147491
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/147491 | Compositions, methods and kits for preparing plasminogen and plasmin prepared therefrom | Mar 1, 2010 | Issued |